Kobayashi Shin-Ichiro, Yokoyama Yukihiro, Matsushita Tadashi, Kainuma Motoshi, Ebata Tomoki, Igami Tsuyoshi, Sugawara Gen, Takahashi Yu, Nagino Masato
Division of Surgical Oncology, Department of Surgery.
Arch Surg. 2012 Oct;147(10):909-17. doi: 10.1001/archsurg.2012.998.
To investigate the association between changes in procoagulant/fibrinolytic factors and thrombotic complications following a major hepatectomy. Little information is available regarding the changes in procoagulant/fibrinolytic factors (such as the von Willebrand factor [vWF] and a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13 [ADAMTS13]), following a major hepatectomy.
Patients who underwent a major hepatectomy from 2010 to 2011 were enrolled. Patients who underwent a pancreatoduodenectomy (PD) during the same period were also observed as controls, for whom operation time and amount of intraoperative blood loss were comparable to those of the patients who underwent a major hepatectomy. Blood samples were prospectively collected to measure various procoagulant/fibrinolytic factors, including vWF and ADAMTS13.
Nagoya University Hospital, Japan.
A total of 50 patients who underwent a major hepatectomy and a total of 23 patients who underwent a PD.
The levels of vWF in the patients who underwent a major hepatectomy increased from before the operation to the seventh postoperative day and were significantly higher than those observed in the patients who underwent a PD. The ADAMTS13 activity in the patients who underwent a major hepatectomy gradually decreased throughout the first 14 postoperative days. In contrast, ADAMTS13 activity in the patients who underwent a PD returned to nearly normal levels within 2 weeks. Three patients who underwent a major hepatectomy had clinically significant thrombotic complications within the first 2 weeks after surgery; however, none of the patients who underwent a PD had thrombotic complications. The vWF to ADAMTS13 ratios of the 3 patients who experienced thrombotic complications were extremely high even before the occurrence of complications. No other procoagulant/fibrinolytic factors showed a marked association with thrombotic events. The vWF to ADAMTS13 ratio was significantly correlated with the estimated liver remnant volume (P < .001) but not with other preoperative or intraoperative factors.
The vWF to ADAMTS13 ratio may be a potentially useful marker in predicting thrombotic complications following a major hepatectomy.
探讨大肝切除术后促凝/纤溶因子变化与血栓形成并发症之间的关联。关于大肝切除术后促凝/纤溶因子(如血管性血友病因子[vWF]和含血小板反应蛋白基序的解聚素和金属蛋白酶13[ADAMTS13])的变化,目前所知甚少。
纳入2010年至2011年接受大肝切除术的患者。同期接受胰十二指肠切除术(PD)的患者也作为对照进行观察,其手术时间和术中失血量与接受大肝切除术的患者相当。前瞻性采集血样以检测各种促凝/纤溶因子,包括vWF和ADAMTS13。
日本名古屋大学医院。
共50例接受大肝切除术的患者和23例接受PD的患者。
接受大肝切除术的患者vWF水平从术前至术后第7天升高,且显著高于接受PD的患者。接受大肝切除术的患者ADAMTS13活性在术后前14天逐渐降低。相比之下,接受PD的患者ADAMTS13活性在2周内恢复至接近正常水平。3例接受大肝切除术的患者在术后前2周内出现了具有临床意义的血栓形成并发症;然而,接受PD的患者均未出现血栓形成并发症。3例发生血栓形成并发症的患者,其vWF与ADAMTS13比值在并发症发生前就极高。没有其他促凝/纤溶因子与血栓形成事件显示出明显关联。vWF与ADAMTS13比值与估计的肝剩余体积显著相关(P <.001),但与其他术前或术中因素无关。
vWF与ADAMTS13比值可能是预测大肝切除术后血栓形成并发症的一个潜在有用指标。